跳至主要内容
临床试验/JPRN-UMIN000053542
JPRN-UMIN000053542尚未招募Unknown

Observational study on the usefulness of telemedicine for patients initiating house dust mite sublingual immunotherapy - Observational study on the usefulness of telemedicine for patients initiating house dust mite sublingual immunotherapy

Pauroom, Clinic for Children and Parents0 个研究点目标入组 20 人开始时间: 2024年2月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Telemedicine group 1) Patients who have received or are receiving house dust mite immunotherapy 2) Patients with a nasal disease (e.g., nasal polyps, deviated septum, hypertrophic rhinitis, etc.) to the extent that it interferes with the evaluation for effectiveness 3) Patients on anti-immunoglobulin E (IgE) antibody products, human anti-human interleukin (IL)-4/13 receptor monoclonal antibodies, or other antibody products indicated for allergic diseases 4) Patients with concomitant severe bronchial asthma (in adults) or severe persistent bronchial asthma (in children) 5) Patients who are lactating, pregnant, or hoping to become pregnant 6) Patients participating in other clinical researches or clinical trials involving interventions 7) Patients deemed unsuitable as research subjects by the principal investigator or sub-investigators Face-to-face treatment group Data on patients who do not violate any of the following criteria at the index date will be extracted from the database. However, exclusion criteria 1) is not applicable. 1) Patients with a history of telemedicine on the same day as the date of prescription of hyposensitization therapy drugs containing mite allergen extracts (allergen immunotherapy drugs) for house dust mite sublingual immunotherapy on or after the index date 2) Patients with a concomitant nasal disease (e.g., nasal polyps, deviated septum, hypertrophic rhinitis, etc.) 3) Patients on IgE antibody products, IL-4/13 receptor monoclonal antibodies, or other antibody products indicated for allergic diseases 4) Patients with concomitant severe bronchial asthma (in adults) or severe persistent bronchial asthma (in children) 5) Patients who are lactating, pregnant, or hoping to become pregnant

研究者

发起方
Pauroom, Clinic for Children and Parents

相似试验

Observational study on the usefulness of... | 临床试验